
Reviewing Drug Product Batch Records
Mark Powell
60 Min
Product Id: 706287
Batch record review is an important step in the release of a medicinal product. This webinar sets out the regulatory requirements for batch records and sets out a systematic approach for review. Trending of batch data is also discussed.

Breaking the Mold: Best Practices for Mycotoxins Prevention and Control in Food
Michael Brodsky
60 Min
Product Id: 705848
This webinar will discuss what are Mycotoxins, classifications, contamination methods, the Regulations & Recommendations on Maximum Mycotoxin Levels, the risk management and prevention strategies to identify and control the contamination. You will learn the best agriculture practices, storage practices, dispatch and transport practices to prevent contamination.

Recurring Deficiencies in Compilations and Reviews and How to Avoid Them - SSARS Procedures, Reports and Accounting Matters
Christy Foister
60 Min
Product Id: 704538
This webinar will discuss common deficiencies that are discovered in compilation and review engagements, as a result of peer review. It will explain the difference between minor deficiencies and major deficiencies. Instructor will discuss how to avoid these common mistakes and what the most common deficiencies are.

Troubleshooting Dissolution Methods for Solid Oral Dosage Forms
Mark Powell
60 Min
Product Id: 706599
The root cause of variable or inconsistent data from compendial dissolution tests can be difficult to identify. Formulation, equipment, operator error and incorrect calculation may be factors. This webinar presents a systematic, logical approach to investigating anomalous dissolution results.

Best Practices in Preparation for an FDA Computer System Audit
Carolyn Troiano
90 Min
Product Id: 706354
FDA requires that all computer systems used to produce, manage and report on “GxP” (GMP, GLC, GCP) related products be validated and maintained in accordance with specific rules. This webinar will help you understand the FDA’s current thinking on computer systems that are validated and subject to inspection and audit. It will also consider areas where FDA will likely focus their effort, including on the higher-risk systems. It will cover areas that will help you to plan for an on-site inspection.

How to Prepare a Standard Operating Procedure (SOP)?
Dr. Afsaneh Motamed Khorasani
60 Min
Product Id: 705131
This webinar will detail a step-by-step procedure on how to write a practical, effective and compliant Standard Operating Procedures (SOPs), review and revise SOPs and maintain compliance over the course of the SOP life-time.

Promoting and Advertising Dietary Supplements in Compliance with FDA and FTC Regulations
Travis Austin MacKay
120 Min
Product Id: 702317
This 2-hr webinar will review the FDA and FTC regulations for promoting and advertising dietary supplements, walk you through real-life case studies, help you address compliance, and tell you how to respond to an FDA enforcement action.

Tax Evasion and Tax Fraud - What it means to you when monitoring BSA and filing SARs
Doug Keipper
60 Min
Product Id: 703110
This training on BSA compliance will help you understand the concept of tax evasion and tax fraud and the difference between the two. Learn the best practices to identify tax fraud and how to report suspicious activity.

Advanced Cash Flow Analysis-EBITDA, UCA Cash Flow, Cash Basis Cash Flow, Fixed-Charge Coverage and Free Cash Flow
David L Osburn
90 Min
Product Id: 705340
This webinar training will explore multiple models of both business and personal (business owner) cash flow analyses. Various cash flow projections and sensitivity analyses will also be explored. The webinar will conclude with commercial real estate (CRE) cash flow analysis and other related real estate investment cash flow models.

An Advanced Course on Lean Documents, Lean Configuration and Document Control
Jose Mora
90 Min
Product Id: 701653
In this training, learn the different types of lean documents and the usage of lean document principles; types of controlled documents; examples of lean and non-lean controlled documents. Pros and cons of lean vs. non-lean documents.

US FDA Medical Device QSR, 21 CFR 820 and Quality Management System
John E Lincoln
90 Min
Product Id: 705794
Learn the basic overview of the original medical device Quality Management System -- The US FDA’s CGMP, Quality System Regulation (QSR) under 21 CFR 820. Implementation, training requirements and content, and annual internal audit / inspection expectations. The FDA’s four key areas of compliance under QSIT.

AML High-Risk Transactions - Identify, Manage and Resolve
Jim George
90 Min
Product Id: 704792
This webinar will discuss the techniques for controlling and managing High Risk Transaction. The Instructor will discuss the parameters for identifying and qualifying transactions as high risk and process and communication to be followed. He will also discuss how to resolve the end result.

Developing a Risk-Based Audit Program
Richard Cascarino
60 Min
Product Id: 703566
In this webinar attendees will gain an understanding of how to develop a practical tailored action plan for their own audit function. Whether you have been charged with establishing a risk audit framework for your organization, want to increase the effectiveness of the existing risk-based audit process or wish to benchmark against emerging best practice, this is the webinar for you.

Dietary Supplements - Regulatory Compliance Requirements, Product Claims, Labeling Issues and FDA Updates
Travis Austin MacKay
90 Min
Product Id: 702154
This training will review the dietary supplement regulations in the USA and explain how to verify that your products are compliant with the most recent regulations and provisions. It covers the FDA regulatory structure and considerations for manufacturing, labeling and advertising dietary supplements.

Identity Issues in Banking - After the Breach, 26 Red Flags and More
Jim George
60 Min
Product Id: 704664
This webinar training helps attendees to understand the problems with 26 Red flags released by federal regulators in regards to identity fraud. The instructor will discuss how to create and implement the fraud control program and Identity solutions to combat ID theft and reduce future losses.

Supplier Management: Challenges and Opportunities
Jeff Kasoff
60 Min
Product Id: 700193
Attend this webinar to learn the QSR and ISO requirements for supplier evaluation, including defining the types of suppliers that require evaluation, including “critical” suppliers and outsourced processes. The QSR and ISO requirements for supplier assessment will be defined as well. The webinar will discuss the application of a risk-based process resulting in a customized supplier management system.

Understanding ESG in the Banking Industry
Stanley Epstein
60 Min
Product Id: 706785
Surface temperature on the Earth have risen at a record pace in recent decades, creating risks to life, ecosystems, and economies. Climate science warns us that further warming is unavoidable over the next decade, and probably after that as well. Climate change poses a real threat and a huge risk to banks as key providers of finance for commerce and industry.

Excel: Power Pivot - Taking Pivot Tables to the Next Level
Mike Thomas
60 Min
Product Id: 705025
In this training attendees will learn how Power Pivot provides business Intelligence functionality and reporting within the familiar environment of Excel with practical examples. This webinar will discuss best practices for importing data into Excel from external sources, creating relationships in Power Pivot, Power Query data sources, and more.

FDA Compliance and Enforcement Trends focused on Data Integrity
Carolyn Troiano
90 Min
Product Id: 706353
FDA requires that all computer systems used to produce, manage and report on “GxP” (GMP, GLC, GCP) related products be validated and maintained in accordance with specific rules. This webinar will help you understand the FDA’s current thinking on computer systems that are validated and subject to inspection and audit.

21 CFR Part 111 - Current FDA 483 Observations and Warning Letters Review
Andy Swenson
60 Min
Product Id: 706772
The FDA inspects facilities, online marketing collateral and physical products to determine compliance with the 21 CFR Part 111 dietary supplement regulations. It is very helpful to review their observations to infer what their priorities are and where industries and companies alike can improve.